Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Market Analysis and Insights: Global Life Science Instruments & Reagents Market
Prior to COVID-19, the market for Life Science Instruments & Reagents was anticipated to grow from US$ 65505 million in 2020 to US$ 91400 million by 2027; it is expected to grow at a CAGR of 5.57% during 2021-2027, whereas post-COVID-19 scenario, the market for Life Science Instruments & Reagents is projected to grow from US$ 67413 million in 2020 (a change by ~2.9% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ 95708 million by 2027; it is expected to grow at a CAGR of 5.93% during 2021-2027. The solicitation of proposals by the governments and public-private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Life Science Instruments & Reagents market.
Global Life Science Instruments & Reagents Scope and Market Size
Life Science Instruments & Reagents market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Life Science Instruments & Reagents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
By Company
Thermo Fisher Scientific
Merck
Danaher
GE Healthcare
BD
Roche
Agilent Technologies
BioMerieux
Bio-Rad Laboratories
PerkinElmer
Waters
Bruker
Shimadzu
Abcam
Segment by Type
Instruments
Reagents
Segment by Application
Commercial & Academic
Clinic
Research Center
By Region
North America
Europe
Japan
China
Southeast Asia
India
Prior to COVID-19, the market for Life Science Instruments & Reagents was anticipated to grow from US$ 65505 million in 2020 to US$ 91400 million by 2027; it is expected to grow at a CAGR of 5.57% during 2021-2027, whereas post-COVID-19 scenario, the market for Life Science Instruments & Reagents is projected to grow from US$ 67413 million in 2020 (a change by ~2.9% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ 95708 million by 2027; it is expected to grow at a CAGR of 5.93% during 2021-2027. The solicitation of proposals by the governments and public-private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Life Science Instruments & Reagents market.
Global Life Science Instruments & Reagents Scope and Market Size
Life Science Instruments & Reagents market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Life Science Instruments & Reagents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
By Company
Thermo Fisher Scientific
Merck
Danaher
GE Healthcare
BD
Roche
Agilent Technologies
BioMerieux
Bio-Rad Laboratories
PerkinElmer
Waters
Bruker
Shimadzu
Abcam
Segment by Type
Instruments
Reagents
Segment by Application
Commercial & Academic
Clinic
Research Center
By Region
North America
Europe
Japan
China
Southeast Asia
India
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
